Advertisement

ASO Author Reflections: Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei

  • Joal D. Beane
  • Haroon A. ChoudryEmail author
ASO Author Reflections
  • 15 Downloads

Notes

Disclosures

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Kitai T. Pulmonary metastasis from pseudomyxoma peritonei. Gastroenterol Res Pract. 2012;2012:690256.CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Pestieau SR, Esquivel J, Sugarbaker PH. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol. 2000;7(3):199–203.CrossRefGoogle Scholar
  3. 3.
    Mortman KD, Sugarbaker PA, Shmookler BM, DeGuzman VC, Soberman MS. Pulmonary metastases in pseudomyxoma peritonei syndrome. Ann Thorac Surg. 1997;64(5):1434–1436.CrossRefGoogle Scholar
  4. 4.
    Geisinger KR, Levine EA, Shen P, Bradley RF. Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review. Am J Clin Pathol. 2007;127(1):135–143.CrossRefGoogle Scholar
  5. 5.
    Ghosh RK, Somasundaram M, Ravakhah K, Hassan C. Pseudomyxoma peritonei with intrathoracic extension: a rare disease with rarer presentation from low-grade mucinous adenocarcinoma of the appendix. BMJ Case Rep. 2016;2016.Google Scholar
  6. 6.
    Grotz TE, Mansfield PF, Royal RE, Mann GN, Rafeeq S, Beaty KA, et al. Intrathoracic chemoperfusion decreases recurrences in patients with full-thickness diaphragm involvement with mucinous appendiceal adenocarcinoma. Ann Surg Oncol. 2016;23(9):2914–2919.CrossRefGoogle Scholar
  7. 7.
    Khan AA, Tambiah J, Cane P, Lang-Lazdunski L. Prolonged survival in a patient with recurrent pulmonary metastases secondary to mucinous cystadenocarcinoma of the appendix with pseudomyxomatous peritonei. Ann Thorac Surg. 2007;83(5):1893–1894.CrossRefGoogle Scholar
  8. 8.
    Beane JD, Wilson, GC, Sutton, JM, et al. Pleuropulmonary recurrence following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for appendiceal pseudomyxoma peritonei. Ann Surg Oncol. 2019.  https://doi.org/10.1245/s10434-018-07091-z.Google Scholar
  9. 9.
    Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Eur J Surg Oncol. 2013;39(11):1207–1213.CrossRefGoogle Scholar
  10. 10.
    Wong JF, Tan GH, Wang W, Soo KC, Teo MC. Repeat cytoreductive surgery and HIPEC for peritoneal surface malignancy and peritoneal carcinomatosis. World J Surg. 2015;39(6):1578–1583.CrossRefGoogle Scholar
  11. 11.
    Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, et al. Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol. 2013;107(4):329–334.CrossRefGoogle Scholar
  12. 12.
    Ahmed S, Levine EA, Randle RW, Swett KR, Shen P, Stewart JH, et al. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21(13):4226–4231.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Division of Surgical OncologyUniversity of Pittsburgh Medical CenterPittsburghUSA

Personalised recommendations